title: Biochemical correlates of neuropsychiatric illness in maple syrup urine disease.
abstract: Maple syrup urine disease (MSUD) is an inherited disorder of branched chain amino acid metabolism presenting with neonatal encephalopathy, episodic metabolic decompensation, and chronic amino acid imbalances. Dietary management enables survival and reduces risk of acute crises. Liver transplantation has emerged as an effective way to eliminate acute decompensation risk. Psychiatric illness is a reported MSUD complication, but has not been well characterized and remains poorly understood. We report the prevalence and characteristics of neuropsychiatric problems among 37 classical MSUD patients (ages 5-35 years, 26 on dietary therapy, 11 after liver transplantation) and explore their underlying mechanisms. Compared with 26 age-matched controls, MSUD patients were at higher risk for disorders of cognition, attention, and mood. Using quantitative proton magnetic resonance spectroscopy, we found lower brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients, which correlated with specific neuropsychiatric outcomes. Asymptomatic neonatal course and stringent longitudinal biochemical control proved fundamental to optimizing long-term mental health. Neuropsychiatric morbidity and neurochemistry were similar among transplanted and nontransplanted MSUD patients. In conclusion, amino acid dysregulation results in aberrant neural networks with neurochemical deficiencies that persist after transplant and correlate with neuropsychiatric morbidities. These findings may provide insight into general mechanisms of psychiatric illness.
authors.affiliation: Penn State Hershey Neurosciences Institute, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA. emilie@muelly.com
authors.forename: Emilie R
authors.initials: ER
authors.lastname: Muelly
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Moore
authors.forename: Scott C
authors.initials: SC
authors.lastname: Bunce
authors.forename: Julie
authors.initials: J
authors.lastname: Mack
authors.forename: Don C
authors.initials: DC
authors.lastname: Bigler
authors.forename: D Holmes
authors.initials: DH
authors.lastname: Morton
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Strauss
mesh_terms: D000293:Adolescent; D000328:Adult; D000339:Affect; D001007:Anxiety / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D001288:Attention; D001921:Brain / Q000378:metabolism*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003401:Creatine / Q000378:metabolism; D003863:Depression / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D005260:Female; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D007175:Impulsive Behavior / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D016031:Liver Transplantation; D008297:Male; D008375:Maple Syrup Urine Disease / Q000453:epidemiology / Q000378:metabolism / Q000523:psychology* / Q000628:therapy; D015995:Prevalence; D011595:Psychomotor Agitation / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D012306:Risk; D055815:Young Adult
chemical_list: D001224:Aspartic Acid; D018698:Glutamic Acid; C000179:N-acetylaspartate; D003401:Creatine